Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

3.68
Delayed Data
As of May 21
 -0.20 / -5.15%
Today’s Change
1.56
Today|||52-Week Range
5.20
+62.11%
Year-to-Date
No recent news for Rigel Pharmaceuticals Inc.

Today’s Trading

Previous close3.88
Today’s open3.89
Day’s range3.59 - 3.89
Volume721,641
Average volume (3 months)1,266,463
Market cap$342.0M
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)-1.96%
Earnings growth (this year)+20.13%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales24.12
Price/Book2.66

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...-0.42-2.10%
NATRNatures Sunshine Pro...-0.09-0.70%
CYTKCytokinetics Inc+0.06+0.97%
CDTXCidara Therapeutics ...+0.17+1.04%
Data as of 05/21/2015

Financials

Last reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$8.3M
Annual profit (last year)-$90.9M
Net profit margin-1,101.92%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Raul R. Rodriguez
CFO, Executive VP &
Head-Investor Relations
Ryan D. Maynard
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers